G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
15 Febrero 2024 - 7:30AM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, will host a webcast and conference call to provide a
financial and corporate update for the fourth quarter and full year
2023 on Wednesday February 28, 2024, at 8:30 a.m. ET.
To register for the event and receive a dial in number and
unique PIN to access the live conference call, please follow this
link to register online. While not required, it is recommended that
you join 10 minutes prior to the start of the event. A live and
archived webcast will be available on the Events &
Presentations page of the company’s website:
www.g1therapeutics.com. The webcast will be archived on the same
page for 90 days following the event.
About G1 TherapeuticsG1 Therapeutics, Inc. is a
commercial-stage oncology biopharmaceutical company whose mission
is to develop and deliver next-generation therapies that improve
the lives of those affected by cancer, including the Company’s
first commercial product, COSELA® (trilaciclib). The Company is
also evaluating therapies in combination with cytotoxic therapies
and/or immunotherapy in areas of high unmet need including
triple-negative breast cancer and extensive stage small cell lung
cancer. G1’s goal is to provide innovative therapeutic advances for
people living with cancer. G1 is based in Research Triangle Park,
N.C. For additional information, please visit
http://www.g1therapeutics.com and follow us on X (formerly known as
Twitter) @G1Therapeutics and LinkedIn.
G1 Therapeutics® and the G1 Therapeutics logo and
COSELA® and the COSELA logo are trademarks of G1
Therapeutics, Inc.
G1 Therapeutics Contacts:
Will RobertsCommunications OfficerVice President, Investor
Relations and Corporate Communications(919) 907-1944
wroberts@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
G1 Therapeutics (NASDAQ:GTHX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024